SCHEMBL69908

SCHEMBL69908

Cc1cc(O)cc(O)c1Cl

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.75
CHRM1 P11229 1/20 0.75
ALOX15 P16050 1/20 0.75
MAOA P21397 1/20 0.75
TBXA2R P21731 1/20 0.75
ADRA1A P35348 1/20 0.75
HTR2B P41595 1/20 0.75
ACHE P22303 2/20 0.46
ALDH1A1 P00352 3/20 0.45
GAA P10253 2/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 4/20 0.43
HSD17B10 Q99714 3/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
ESR2 Q92731 3/20 0.40
TSHR P16473 2/20 0.40
HSP90AA1 P07900 2/20 0.40
ESR1 P03372 2/20 0.40
TDP1 Q9NUW8 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chloroxylenol SCHEMBL34163 0.86 CYP3A4 (1.00) CYP3A4CHRM1ALOX15MAOATBXA2R
Chloroxylenol SCHEMBL7950378 0.86 CYP3A4 (1.00) CYP3A4CHRM1ALOX15MAOATBXA2R
Chloroxylenol SCHEMBL28179844 0.83 CYP3A4 (0.94) CYP3A4CHRM1ALOX15MAOATBXA2R
SCHEMBL11881446 0.83 HPGD (0.59) CYP3A4CHRM1ALOX15MAOATBXA2R
Chloroxylenol SCHEMBL9272511 0.81 CYP3A4 (0.89) CYP3A4CHRM1ALOX15MAOATBXA2R
SCHEMBL3719666 0.79 CYP3A4 (0.52) CYP3A4CHRM1ALOX15MAOATBXA2R
SCHEMBL6800963 0.79 CYP3A4 (0.75) CYP3A4CHRM1ALOX15MAOATBXA2R
SCHEMBL30433819 0.79 CYP3A4 (0.52) CYP3A4CHRM1ALOX15MAOATBXA2R
SCHEMBL7724604 0.79 ALDH1A1 (0.56) CYP3A4CHRM1ALOX15MAOATBXA2R
Chloroxylenol SCHEMBL12487984 0.77 CYP3A4 (0.80) CYP3A4CHRM1ALOX15MAOATBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0623339-B1 Use of 4-,4- and 5-, or 4- and 6-substituted derivatives of resorcin in cosmetic or dermopharmaceutical compositions for depigmentation OREAL (FR) 1997-07-23 EP claimed
JP-7330513-A None JP disclosed
EP-2479203-A1 AROMATIC POLYESTER Muroran Institute of Technology (JP) 2012-07-25 EP disclosed
US-20120172570-A1 AROMATIC POLYESTER NITTA CORPORATION 2012-07-05 US disclosed
US-8129493-B2 Aromatic polyester MURORAN INSTITUTE OF TECHNOLOGY (JP) 2012-03-06 US disclosed
US-20110224343-A1 MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME MURORAN INSTITUTE OF TECHNOLOGY (JP) 2011-09-15 US disclosed
US-20110092662-A1 AROMATIC POLYESTER NITTA CORPORATION (JP) 2011-04-21 US disclosed
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed
EP-1145083-A2 HYBRID SURFACE MODIFICATION PROCESS AND ARTICLE BMC Industries, Inc. (US) 2001-10-17 EP disclosed
US-4390675-A EPOXYFULVENE, ACID CATALYST ASHLAND OIL, INC. (US) 1983-06-28 US disclosed
EP-0053280-A1 Sealing composition, method for preparing said composition, integrated circuit module sealed therewith, and process for sealing International Business Machines Corporation (US) 1982-06-09 EP disclosed
EP-0009190-B1 CURABLE COMPOSITION USEFUL FOR SCREEN-PRINTING, A CURED COATING COMPRISING SAID COMPOSITION AND PROCESS FOR SOLDERING PRINTED CIRCUIT BOARDS USING SAID COMPOSITION International Business Machines Corporation (US) 1982-04-28 EP disclosed
EP-0039807-A2 Hair-dyeing compositions Henkel Kommanditgesellschaft auf Aktien (DE) 1981-11-18 EP disclosed
EP-0039807-A2 Hair-dyeing compositions Henkel Kommanditgesellschaft auf Aktien (DE) 1981-11-18 EP disclosed
US-4292230-A Screen-printing composition and use thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1981-09-29 US disclosed
US-4258137-A INCORPORATING AN EPOXY RESIN AND CURING AGENT TO ATTAIN RIGIDITY W. R. GRACE & CO. (US) 1981-03-24 US disclosed
US-4250005-A Radiation cross-linked polyurethane foams SCOTT PAPER COMPANY (US) 1981-02-10 US disclosed
EP-0009190-A1 Curable composition useful for screen-printing, a cured coating comprising said composition and process for soldering printed circuit boards using said composition International Business Machines Corporation (US) 1980-04-02 EP disclosed
US-4046744-A Thermosetting coatings based on ketoxime-blocked isocyanates and oxazolidines ROHM AND HAAS COMPANY (US) 1977-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224343-A1 MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME F12, PHAX, WDR82 CYP3A4 2028/4885CHRM1 270/4885ALOX15 1966/4885
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 CYP3A4 177/4885CHRM1 3008/4885ALOX15 1941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.